Concepedia

Kirk Rattanakorn

KR

Statistics

Publications

4

Citations

323

H-Index

4

Active since

2013

Affiliations

New York University(Current)

Kirk Rattanakorn is an author at New York University specializing in oncology, medicine, and signal transduction in cancer.

Publications per year

2013–2017

4

Publications

4

Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells

Upal Basu-Roy, N. Sumru Bayın, Kirk Rattanakorn et al. · Nature Communications · 2015 · 247 citations · Full text

, , +17

PPARγ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity

Upal Basu-Roy, Eugenia J. Han, Kirk Rattanakorn et al. · Oncotarget · 2016 · 47 citations · Full text

, , +14

DevStaR: High-Throughput Quantification of C. elegans Developmental Stages

Amelia White, Brandon Lees, Huey‐Ling Kao et al. · IEEE Transactions on Medical Imaging · 2013 · 15 citations · Full text

, , +17

Survival benefits in colorectal adenocarcinoma with the use of metformin among a black diabetic inner city population

Roger Zhu, Kirk Rattanakorn, Steven Pham et al. · Colorectal Cancer · 2017 · 14 citations

, , +17

1–4 of 4